217 related articles for article (PubMed ID: 1425740)
1. In vitro activity of L-627 against anaerobic bacteria.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of anaerobic bacteria to meropenem.
Nord CE; Lindmark A; Persson I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
[TBL] [Abstract][Full Text] [Related]
3. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
4. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
Watt B; Naden M
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of anaerobic bacteria to tosufloxacin.
Nord CE; Lindmark A; Persson I; Runow C
Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):263-5. PubMed ID: 1597207
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of anaerobic bacteria to PD 131628.
Nord CE; Hagelbäck A
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):68-71. PubMed ID: 1314176
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1993 Oct; 12(10):784-6. PubMed ID: 7802861
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
Nord CE; Olsson-Liljequist B
Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
[TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
Schumacher U; Manncke B; Gerbracht K; Werner H
Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
Edlund C; Sabouri S; Nord CE
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):193-5. PubMed ID: 9665302
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria.
Rylander M; Nord CE; Norrby SR
Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):919-24. PubMed ID: 2512142
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of imipenem against anaerobic bacteria.
Wexler HM; Finegold SM
Rev Infect Dis; 1985; 7 Suppl 3():S417-25. PubMed ID: 3901206
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of HMR 3647 against anaerobic bacteria.
Edlund C; Sillerström E; Wahlund E; Nord CE
J Chemother; 1998 Aug; 10(4):280-4. PubMed ID: 9720465
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of imipenem against gram-positive anaerobic bacteria.
Dubreuil L; Devos J; Romond C
Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
Nord CE; Olsson-Liljequist B
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
[TBL] [Abstract][Full Text] [Related]
19. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
Antimicrob Agents Chemother; 2013 Jun; 57(6):2620-30. PubMed ID: 23529731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]